NanoCarrier Co Ltd (4571.T)

4571.T

About

NanoCarrier Co., Ltd. is a Japan-based biopharmaceutical products developer. The Company develops biopharmaceutical products focused on the medication of cancer and other intractable diseases. It is engaged in the research, development, manufacture, and sale of anti-cancer drugs based on micellar nanoparticle technology. The... (more)

Buy/Sell

No analyst recommendations are available for 4571.T.

» Analyst Consensus

Overall

Beta:	1.76
Market Cap (Mil.):	¥81,073.22
Shares Outstanding (Mil.):	0.33
Dividend:	--
Yield (%):	--

Financials

	4571.T	Industry	Sector
P/E (TTM):	--	39.38	31.28
EPS (TTM):	-1,909.72	--	--
ROI:	-10.75	2.42	18.90
ROE:	-15.48	3.64	19.80

Latest News about 4571.T

» More 4571.T News

Earnings vs. Estimates

Analyst Research Reports

Report Title	Price
Thomson Reuters Stock Report - NANOCARRIER COMPANY LIMITED (4571-TO) Provider: Thomson Reuters Stock Report	$25.00 Buy
Wright Investors Service Comprehensive Report for Nanocarrier Company Limited Provider: Wright Reports	$449.00 Buy
NanoCarrier Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. Provider: Reuters Investment Profile	$20.00 Buy
NanoCarrier FY03/13 Report Update Provider: Shared Research Inc.	$0.00 Buy
MONTHLY WRAP – May 2013 Provider: Shared Research Inc.	$0.00 Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Related Topics:

Edition:

U.S.
- Arabic
- Argentina
- Brazil
- Canada
- China
- France
- Germany
- India
- Italy
- Japan
- Latin America
- Mexico
- Russia
- Spain
- United Kingdom

Back to top

Reuters.com

Legal

Support & Contact

Connect with Reuters

About

Our Flagship financial information platform incorporating Reuters Insider

An ultra-low latency infrastructure for electronic trading and data distribution

A connected approach to governance, risk and compliance

Our next generation legal research platform

Our global tax workstation

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.